CELLINI, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 2.133
EU - Europa 2.004
AS - Asia 1.215
SA - Sud America 22
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
Totale 5.386
Nazione #
US - Stati Uniti d'America 2.112
GB - Regno Unito 934
CN - Cina 908
SG - Singapore 218
SE - Svezia 181
RU - Federazione Russa 158
FR - Francia 146
FI - Finlandia 136
IE - Irlanda 136
IT - Italia 132
DE - Germania 94
UA - Ucraina 39
BE - Belgio 24
KR - Corea 23
JP - Giappone 20
BR - Brasile 19
CA - Canada 17
VN - Vietnam 14
HK - Hong Kong 5
ID - Indonesia 5
AU - Australia 4
NL - Olanda 4
ES - Italia 3
PA - Panama 3
PT - Portogallo 3
TR - Turchia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AT - Austria 2
AZ - Azerbaigian 2
CH - Svizzera 2
CL - Cile 2
EU - Europa 2
IN - India 2
LV - Lettonia 2
MA - Marocco 2
PK - Pakistan 2
PL - Polonia 2
SA - Arabia Saudita 2
BD - Bangladesh 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
IR - Iran 1
LT - Lituania 1
LU - Lussemburgo 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 5.386
Città #
Southend 863
Jacksonville 325
Chandler 323
Ann Arbor 271
Woodbridge 261
Singapore 172
Houston 154
Beijing 139
Dublin 136
Jinan 93
Ashburn 86
Shenyang 82
Verona 81
Nanjing 77
Wilmington 74
Lawrence 58
Princeton 58
Hebei 45
New York 40
Ningbo 35
Tianjin 35
Changsha 32
Nanchang 32
Zhengzhou 31
Helsinki 30
Haikou 29
Seattle 24
Brussels 23
Lanzhou 23
Taiyuan 22
Jiaxing 21
Seoul 21
Hangzhou 20
Milan 20
Taizhou 20
Tokyo 18
Fuzhou 17
Boardman 16
Falls Church 13
Guangzhou 12
Lancaster 12
Sindelfingen 11
Norwalk 10
Redwood City 10
San Francisco 9
Chicago 8
Elora 8
Kent 8
Perugia 8
Toronto 8
Auburn Hills 7
Birmingham 7
Dong Ket 7
Santa Clara 7
Dallas 6
Dearborn 6
Los Angeles 6
Kemerovo 5
Redmond 5
Dongguan 4
Jakarta 4
Qingdao 4
Shanghai 4
São Paulo 4
Cambridge 3
Clearwater 3
Detroit 3
Gardone Val Trompia 3
Moscow 3
Riva 3
Tappahannock 3
Xi'an 3
Baku 2
Belo Horizonte 2
Berlin 2
Chongqing 2
Fairfield 2
Hong Kong 2
Islamabad 2
Kirrweiler 2
Kochi 2
Nashville 2
Saint Louis 2
Sydney 2
Tomsk 2
Achinsk 1
Amsterdam 1
Antwerp 1
Asti 1
Auckland 1
Augusta 1
Bangkok 1
Boston 1
Bratislava 1
Budapest 1
Büdelsdorf 1
Casablanca 1
Central 1
Changzhou 1
Chengdu 1
Totale 4.065
Nome #
Allele-specific Characterization of Alanine: Glyoxylate Aminotransferase Variants Associated with Primary Hyperoxaluria 166
Biochemical and computational approaches to improve the clinical treatment of Dopa decarboxylase-related diseases: an overview 164
Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase 148
Dimerization and Folding Processes of Treponema denticola Cystalysin: The Role of Pyridoxal 5'-Phosphate 143
Holo-and apocystalysin from Treponema denticola: two different conformations 137
Pyridoxal 5’-Phosphate Enzymes as Targets for Therapeutic Agents 137
Characterization of C-S Lyase from C. diphtheriae: A Possible Target for New Antimicrobial Drugs 122
Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications 112
S-Glutathionylation at Cys328 and Cys542 Impairs STAT3 Phosphorylation 108
S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine 108
Construction, purification and characterization of untagged human liver alanine-glyoxylate aminotransferase expressed in Escherichia coli 107
Identification by Virtual Screening and In Vitro Testing of Human DOPA Decarboxylase Inhibitors 105
A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency: from molecular mechanisms to therapy implications 105
Interaction of Human Dopa Decarboxylase with L-Dopa: Spectroscopic and Kinetic Studies as a Function of pH 104
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: Glyoxylate aminotransferase and the F152I mutation 100
Site-directed mutagenesis provides insight into racemization of alanine catlayzed by "Treponema denticola" cystalysin 99
Crystal structure of the S187F variant of human liver alanine: Aminotransferase associated with primary hyperoxaluria type I and its functional implications 99
Astrocytes regulate the expression of Insulin-Like Growth Factor 1 Receptor (IGF1-R) in primary cortical neurons during in vitro senescence 99
Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. 98
Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I. 97
Tat-mediated delivery of human alanine:glyoxylate aminotransferase in a cellular model of Primary Hyperoxaluria Type I 97
A novel pathway for metabolism of the cardiovascular risk factor homoarginine by alanine:glyoxylate aminotransferase 2 97
Quercetin prevents glutathione depletion induced by dehydroascorbic acid in rabbit red blood cells 92
Cystalysin: an example of the catalytic versatility of pyridoxal 5'-phosphate dependent enzymes 92
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 92
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes 92
Caenorhabditis elegans AGXT-1 is a mitochondrial and temperature-adapted ortholog of peroxisomal human AGT1: New insights into between-species divergence in glyoxylate metabolism 92
Folding pathway of the pyridoxal 5'-phosphate C-S lyase MalY from Escherichia coli 91
Human liver peroxisomal alanine:glyoxylate aminotransferase: Characterization of the two allelic forms and their pathogenic variants. 91
Radiation damage at the active site of human alanine:glyoxylate aminotransferase reveals that the cofactor position is finely tuned during catalysis 91
PLP-Dependent Enzymes 90
Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview. 90
Effects of interface mutations on the dimerization of alanine glyoxylate aminotransferase and implications in the mistargeting of the pathogenic variants F152I and I244T 90
An engineered folded PLP-bound monomer of Treponema denticola cystalysin reveals the effect of the dimeric structure on the catalytic properties of the enzyme 89
Insights into the mechanism of oxidative deamination catalyzed by Dopa decarboxylase 88
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: glyoxylate aminotransferase and the f152i mutation 87
Spectroscopic and kinetic analyses reveal the pyridoxal 5'-phosphate binding mode and the catalytic features of Treponema denticola cystalysin 87
S81 L and G170R mutations causing Primary Hyperoxaluria Type I in homozygosis and heterozygosis: an example of positive interallelic complementation. 86
Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine 86
The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I 85
Intracellular ascorbic acid enhances the DNA single-strand and toxicity induced by peroxynitrite in U937 cells 83
A quinonoid is an intermediate of oxidative deamination reaction catalyzed by Dopa decarboxylase 83
Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I 83
Lysine 238 is an essential residue for alfa, beta- elimination catalyzed by "Treponema denticola" cystalysin 77
Probing the role of Tyr 64 of Treponema denticola cystalysin by site-directed mutagenesis and kinetic studies 77
Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency. 73
Treponema denticola cystalysin catalyzes beta-desulfination of L-cysteine sulfinic acid and beta-decarboxylation of L-aspartate and oxalacetate 71
Treponema denticola cystalysin exhibits a significant alanine racemase activity accompanied by transamination: mechanistic implications 71
Oligomeric state and thermal stability of apo- and holo- human ornithine δ-aminotransferase 70
Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases. 69
Rapid profiling of disease alleles using a tunable reporter of protein misfolding 69
Natural and unnatural compounds rescue folding defects of human alanine:glyoxylate aminotransferase leading to Primary Hyperoxaluria Type I 68
Role of N-acetyilaspartate (NAA) and N-acetyl-aspartyl-glutamate (NAAG) in early stage of pilocarpine induced status epilepticus in rat 67
Molecular and biochemical methods to assess the biological impact of Quantum Dots 66
Crystal structure of Aspergillus fumigatus AroH, an aromatic amino acid aminotransferase 66
Molecular insights into primary hyperoxaluria Type I pathogenesis. 65
Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I. 64
Targeting Cystalysin, a Virulence Factor ofTreponema denticola-Supported Periodontitis 58
Totale 5.443
Categoria #
all - tutte 18.239
article - articoli 17.149
book - libri 0
conference - conferenze 825
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 265
Totale 36.478


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020427 0 0 0 0 0 0 77 35 38 85 32 160
2020/2021625 142 123 47 52 67 48 11 38 16 6 52 23
2021/2022711 60 250 102 31 19 13 9 41 23 10 29 124
2022/2023988 77 110 83 168 93 228 22 53 118 4 16 16
2023/2024406 23 35 22 44 36 66 6 32 3 27 84 28
2024/2025498 67 85 16 215 65 49 1 0 0 0 0 0
Totale 5.443